Mathematical modeling in cancer nanomedicine: a review (Q64075041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

2 references

8 February 2021

30 June 2021

Mathematical modeling in cancer nanomedicine: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

0 references

0 references

1 reference

8 February 2021

1 reference

30 June 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Yao-Li Chuang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Shreya Goel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

7

Vittorio Cristini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

author name string

Joseph D Butner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Sergio Caserta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

C Jeffrey Brinker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Zhihui Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

language of work or name

English

0 references

publication date

4 April 2019

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

8 February 2021

30 June 2021

Biomedical Microdevices

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

8 February 2021

30 June 2021

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

page(s)

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

2 May 2020

copyright license

2 references

8 February 2021

https://scigraph.springernature.com/pub.10.1007/s10544-019-0380-2

30 June 2021

exact match

0 references

cites work

Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension

1 reference

12 December 2020

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1 reference

12 December 2020

Physiologically Based Pharmacokinetic Modeling: Principles and Applications

1 reference

12 December 2020

Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

Continuous and discrete mathematical models of tumor-induced angiogenesis.

1 reference

12 December 2020

Scale-invariant behavior and vascular network formation in normal and tumor tissue

1 reference

12 December 2020

The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma

1 reference

12 December 2020

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

1 reference

12 December 2020

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

1 reference

12 December 2020

Nonlinear simulation of tumor growth.

1 reference

12 December 2020

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

1 reference

12 December 2020

Announcing the worldwide Protein Data Bank

1 reference

12 December 2020

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

1 reference

12 December 2020

A theoretical model for the margination of particles within blood vessels.

1 reference

12 December 2020

Coarse-grained models for proteins

1 reference

12 December 2020

Mechanics of receptor-mediated endocytosis

1 reference

12 December 2020

Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.

1 reference

12 December 2020

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

1 reference

12 December 2020

The effective dispersion of nanovectors within the tumor microvasculature.

1 reference

12 December 2020

The adhesive strength of non-spherical particles mediated by specific interactions.

1 reference

12 December 2020

Analytical model of magnetic nanoparticle transport and capture in the microvasculature

1 reference

12 December 2020

Pros and cons of the liposome platform in cancer drug targeting

1 reference

12 December 2020

Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice

1 reference

12 December 2020

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

1 reference

12 December 2020

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

1 reference

12 December 2020

Renal clearance of quantum dots

1 reference

12 December 2020

Liposomal nanomedicines

1 reference

12 December 2020

The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology.

1 reference

12 December 2020

The receptor-mediated endocytosis of nonspherical particles

1 reference

12 December 2020

Multiscale modelling and nonlinear simulation of vascular tumour growth.

1 reference

12 December 2020

Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging

1 reference

12 December 2020

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

1 reference

12 December 2020

To scale or not to scale: the principles of dose extrapolation

1 reference

12 December 2020

Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer

1 reference

12 December 2020

[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model

1 reference

12 December 2020

Design of bio-mimetic particles with enhanced vascular interaction

1 reference

12 December 2020

Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements

1 reference

12 December 2020

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

1 reference

12 December 2020

Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows

1 reference

12 December 2020

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles

1 reference

12 December 2020

Modeling the time evolution of the nanoparticle-protein corona in a body fluid

1 reference

12 December 2020

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer

1 reference

12 December 2020

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

1 reference

12 December 2020

Delivering nanomedicine to solid tumors

1 reference

12 December 2020

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging.

1 reference

12 December 2020

Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages.

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of nanoparticles

1 reference

12 December 2020

Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation

1 reference

12 December 2020

Mifamurtide for the treatment of nonmetastatic osteosarcoma

1 reference

12 December 2020

Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment

1 reference

12 December 2020

Multiscale cancer modeling

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development

1 reference

12 December 2020

Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging

1 reference

12 December 2020

Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging.

1 reference

12 December 2020

Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution

1 reference

12 December 2020

ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance

1 reference

12 December 2020

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

1 reference

12 December 2020

The role of physiologically based pharmacokinetic modeling in regulatory review

1 reference

12 December 2020

Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening

1 reference

12 December 2020

Influence of Red Blood Cells on Nanoparticle Targeted Delivery in Microcirculation.

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content

1 reference

12 December 2020

Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

1 reference

12 December 2020

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

1 reference

12 December 2020

The effect of nanoparticle size, shape, and surface chemistry on biological systems

1 reference

12 December 2020

In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics

1 reference

12 December 2020

A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

1 reference

12 December 2020

Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model

1 reference

12 December 2020

Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry

1 reference

12 December 2020

Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine

1 reference

12 December 2020

Biomolecular coronas provide the biological identity of nanosized materials

1 reference

12 December 2020

The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems

1 reference

12 December 2020

Odyssey of a cancer nanoparticle: from injection site to site of action

1 reference

12 December 2020

A computational model for predicting nanoparticle accumulation in tumor vasculature

1 reference

12 December 2020

Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice

1 reference

12 December 2020

The influence of size, shape and vessel geometry on nanoparticle distribution

1 reference

12 December 2020

Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer

1 reference

12 December 2020

Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer

1 reference

12 December 2020

Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations

1 reference

12 December 2020

On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better.

1 reference

12 December 2020

Mathematical modeling in cancer drug discovery

1 reference

12 December 2020

Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors

1 reference

12 December 2020

Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations Principles, Methods, and Applications in the Pharmaceutical Industry

1 reference

12 December 2020

Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements

1 reference

12 December 2020

Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development

1 reference

12 December 2020

Combined mathematical modelling and experimentation to predict polymersome uptake by oral cancer cells

1 reference

12 December 2020

A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment

1 reference

12 December 2020

Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response

1 reference

12 December 2020

A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats

1 reference

12 December 2020

Transport properties of pancreatic cancer describe gemcitabine delivery and response

1 reference

12 December 2020

Margination of micro- and nano-particles in blood flow and its effect on drug delivery

1 reference

12 December 2020

Simulating cancer growth with multiscale agent-based modeling

1 reference

12 December 2020

Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.

1 reference

12 December 2020

Understanding Drug Resistance in Breast Cancer with Mathematical Oncology

1 reference

12 December 2020

A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors

1 reference

12 December 2020

Dynamic density functional theory of protein adsorption on polymer-coated nanoparticles

1 reference

12 December 2020

Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

1 reference

12 December 2020

Dual-radiolabeled nanoparticle SPECT probes for bioimaging

1 reference

12 December 2020

Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors

1 reference

12 December 2020

Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach

1 reference

12 December 2020

Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Physical Principles of Nanoparticle Cellular Endocytosis.

1 reference

12 December 2020

Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles.

1 reference

12 December 2020

Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions

1 reference

12 December 2020

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

1 reference

12 December 2020

Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.

1 reference

12 December 2020

Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles.

1 reference

12 December 2020

Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill

1 reference

12 December 2020

(99m)Tc-Labeled Multifunctional Low-Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted SPECT/CT Dual-Mode Imaging of Tumors.

1 reference

12 December 2020

Mechanism of hard-nanomaterial clearance by the liver.

1 reference

12 December 2020

Protein adsorption on nanoparticles: model development using computer simulation

1 reference

12 December 2020

Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona

1 reference

12 December 2020

Kinetics of the formation of a protein corona around nanoparticles.

1 reference

12 December 2020

Cancer nanomedicine: progress, challenges and opportunities

1 reference

12 December 2020

Understanding the Kinetics of Protein-Nanoparticle Corona Formation

1 reference

12 December 2020

Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.

1 reference

12 December 2020

Antitumor Effect of Nanoparticle 131I-Labeled Arginine-Glycine-Aspartate-Bovine Serum Albumin-Polycaprolactone in Lung Cancer

1 reference

12 December 2020

Liposomal Formulations in Clinical Use: An Updated Review.

1 reference

12 December 2020

Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.

1 reference

12 December 2020

Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes

1 reference

12 December 2020

Editorial: Special Section on Multiscale Cancer Modeling

1 reference

12 December 2020

A two-step model of TiO2 nanoparticle toxicity in human liver tissue.

1 reference

12 December 2020

Evolution and Clinical Translation of Drug Delivery Nanomaterials

1 reference

12 December 2020

Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling.

1 reference

12 December 2020

Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties

1 reference

12 December 2020

Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity

1 reference

12 December 2020

Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics

1 reference

12 December 2020

10.1007/S10544-019-0380-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30949850%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference